
Anne S. Renteria MD
Hematologic Oncology
Director of the Bone Marrow Transplantation and Cellular Therapy Program and Associate Service Line Leader for Malignant Hematology at Indiana University Health
Join to view full profile
1030 W Michigan StIndianapolis, IN 46202
Phone+1 317-948-6260
Fax+1 516-663-4613
Dr. Renteria is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Blood & Bone Marrow Transplant, 2012 - 2013
Maimonides Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
NYC Health & Hospitals/South Brooklyn HealthChief Residency, Internal Medicine, 2008 - 2009
NYC Health & Hospitals/South Brooklyn HealthResidency, Internal Medicine, 2006 - 2009
Jackson Health SystemPost-Doctoral Fellowship, 2004 - 2005
Certifications & Licensure
IN State Medical License 2024 - 2027
NY State Medical License 2012 - 2027
MD State Medical License 2023 - 2025
NJ State Medical License 2023 - 2025
DC State Medical License 2023 - 2024
VA State Medical License 2022 - 2024
LA State Medical License 2023 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology- Educational Commission for Foreign Medical GraduatesECFMG Certificate
- Join now to see all
Awards, Honors, & Recognition
- Reviewer Biology of Blood and Marrow Transplantation Journal
- Reviewer BMJ Case Reports Journal
- "Honor Your Doctor" Award The Mount Sinai Medical Center, New York, NY, 2013
Clinical Trials
- Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
- Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease
- A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Start of enrollment: 2017 Apr 28
Publications & Presentations
PubMed
- Ancestry-associated social and genomic hallmarks linked with inferior outcome in elderly acute myeloid leukemia.Lacey S Williams, Alexis Williams, Olivia Wilkins, Sarah Mudra, Paul Sackstein
BMC Cancer. 2025-10-27 - 1 citationsPredicting the success of antibody removal with therapeutic plasma exchange: The role of serum dilutions.Nidhi Vantair, Maria Leising, Matthew Najor, Yazan Juma, Dong Hyang Kwon
American Journal of Transplantation. 2025-07-01 - 1 citationsTransplant Eligible and Ineligible Elderly Patients with AML-A Genomic Approach and Next Generation Questions.Jennifer A Marks, Paul Sackstein, Alexis Williams, Rachel Zemel, Jennifer A Marks
Biomedicines. 2024-04-29
Books/Book Chapters
Abstracts/Posters
- Are we crazy? Building a successful acute leukemia and stem cell transplant program during the COVID-19 pandemicTaylor Harrison, MHA, Morgan Fillet, BS, RN, Anne S. Renteria, MD, James Williams, MHA, Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2022
- Implementation of an Acute Leukemia and Stem Cell Transplant Program through a Multidisciplinary Team Approach for Practice ChangeCassidy Smith, PA-C, Morgan Fillet, RN, BS, Martha Wright, PA-C, Julia Wuest, PA-C, Lauren Sheldon, BSN, RN, Kelsey Hawkins-Rusch, MS, RN, CNS, Maria Sbenghe, MD, Saad..., Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2022
- Dose-Adjusted Intensive Chemotherapy is Safe and Tolerable in Older Patients with Ph-Negative Acute Lymphoblastic LeukemiaRenteria AS, Venugopal S, Marcellino B, Keyzner A, Kremyanskaya M, Bar-Nathan M, Najfeld V, Mascarenhas J, Tandem Meeting, Houston, Texas, 2/23/2019
Lectures
- Twentv-Five Years of Advances in Hematology - Burham Lecture SeriesRochester Regional Hospital, Rochester, NY - 3/4/2021
- Achieving quality Cell and Gene Therapies outcomes through multidisciplinary collaborationICON's multidisciplinary approach to CGT clinical trials - Global Webinar - 9/24/2020
- Racial and insurance disparities in multiple myeloma management in a referral center.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Press Mentions
Perlmutter Cancer Center Appoints Renowned Clinician–Scientist to Lead Its Transplantation & Cellular Therapy Center on Long IslandDecember 20th, 2024
Committees
- Member, BMT and Infectious Disease Committee - Mount Sinai Hospital 2017 - 2019
- Member, Takeda - Vedolizumab-GHD Advisory Board Meeting 2017 - 2017
- Member, Chemotherapy Council Committee - Mount Sinai Hospital 2016 - 2019
- Member, Ethics Committee at the Rio de Janeiro Medicine Council (CREMERJ) - University Hospital, Federal University of Rio de Janeiro, Brazil 2000 - 2001
- President, Association of Resident Physicians (AMERHU) - University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Brazil 1999 - 2000
Professional Memberships
- International Society Cell & Gene Therapy (ISCT)Member
- NEJM Catalyst Insights CouncilMember
- European Hematology AssociationMember
- Member
- Member
Other Languages
- Portuguese, French, Spanish
External Links
- Acute Leukemiahttps://vimeo.com/642821327/bb6e8c6229
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:











